DeepTag-GPRC5D targeted CAR-T
/ Shanghai Yake Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 16, 2023
A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: He Huang
CAR T-Cell Therapy • New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 1
Of
1
Go to page
1